Immediate Implant Placement With Provisionalization Using Different Bone Grafts as a Space Filling Material in the Maxillary Esthetic Zone
Launched by MOHAMED TAREK MOHAMED YOUSSIF OMAR · Nov 12, 2018
Trial Information
Current as of May 13, 2025
Unknown status
Keywords
ClinConnect Summary
Placement of implants into extraction sockets targets the maintenance of peri implant hard and soft tissue structures and the support of a natural and esthetic contour. The main advantages of immediate implant insertion in comparison with delayed implant placement protocols are as follows: a reduced treatment time, less number of sessions, and, thus, the less invasive procedure. This study examines the clinical performance (survival rate, marginal bone levels and Pink Esthetic Score \[PES\]) of OsseoSpeed™ implants placed into extraction sockets with immediate provisionalization in the ante...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adult patients with badly broken teeth in upper esthetic zone indicated for extraction
- • Both sexes.
- • No intraoral soft and hard tissue pathology
- • No systemic condition that contraindicate implant placemen
- Exclusion Criteria:
- • Heavy smokers more than 20 cigarettes per day.
- • Patients with systemic disease that may affect normal healing.
- • Psychiatric problems
- • Disorders to implant are related to history of radiation therapy to the head and neck neoplasia
About Mohamed Tarek Mohamed Youssif Omar
Dr. Mohamed Tarek Mohamed Youssif Omar is a distinguished clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive expertise in clinical trial design and management, Dr. Omar focuses on innovative therapeutic interventions across various therapeutic areas. His dedication to ethical research practices and adherence to regulatory standards ensures the integrity and reliability of clinical data. Through collaboration with healthcare professionals and research institutions, Dr. Omar aims to contribute significantly to the scientific community and enhance the efficacy of treatments available to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials